Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
| $4.54M | ﹤0.01% |
174,672
+11,352
| +7% | +$296K |
|
402
SiteOne Landscape Supply
SITE
$4.3B
| $4.51M | ﹤0.01% |
22,619
+12,760
| +129% | +$2.41M |
|
403
Huazhu Hotels Group
HTHT
$13B
| $4.4M | ﹤0.01% |
95,890
-68,262
| -42% | -$3.22M |
|
404
Vertex Pharmaceuticals
VRTX
$123B
| $4.37M | ﹤0.01% |
24,114
-899
| -4% | -$176K |
|
405
Brinker International
EAT
$9.75B
| $4.35M | ﹤0.01% |
88,758
+20
| +0% | +$1.09K |
|
406
US Bancorp
USB
$99.4B
| $4.21M | ﹤0.01% |
70,902
+2,222
| +3% | +$127K |
|
407
Ambev
ABEV
$46.5B
| $4.17M | ﹤0.01% |
1,509,631
-694,109
| -31% | -$2.2M |
|
408
Pentair
PNR
$11.2B
| $4.15M | ﹤0.01% |
57,125
+29,276
| +105% | +$2.18M |
|
|
RDS.B
409
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $4.13M | ﹤0.01% |
93,369
+3,536
| +4% | +$140K |
|
410
Icon
ICLR
$12.4B
| $4.05M | ﹤0.01% |
15,444
-2
| -0% | -$486 |
|
|
SPLK
411
DELISTED
Splunk Inc
SPLK
| $3.98M | ﹤0.01% |
27,482
+2,727
| +11% | +$397K |
|
|
SFBS
412
ServisFirst Bancshares
SFBS
$4.87B
| $3.86M | ﹤0.01% |
49,600
+11,691
| +31% | +$837K |
|
413
IBM
IBM
$220B
| $3.84M | ﹤0.01% |
28,905
+13,411
| +87% | +$1.79M |
|
414
Steel Dynamics
STLD
$37.5B
| $3.82M | ﹤0.01% |
65,295
-5,442
| -8% | -$348K |
|
415
Cooper Companies
COO
$14.3B
| $3.81M | ﹤0.01% |
36,892
-184
| -0.5% | -$19.6K |
|
416
AbbVie
ABBV
$431B
| $3.81M | ﹤0.01% |
35,274
+3,460
| +11% | +$395K |
|
|
MNTV
417
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $3.73M | ﹤0.01% |
190,136
-15,342
| -7% | -$312K |
|
418
VanEck Oil Services ETF
OIH
$1.94B
| $3.68M | ﹤0.01% |
18,667
-185
| -1% | -$35.2K |
|
419
MYR Group
MYRG
$5.16B
| $3.66M | ﹤0.01% |
36,769
+8,351
| +29% | +$821K |
|
420
Worthington Enterprises
WOR
$2.83B
| $3.6M | ﹤0.01% |
110,799
+11,664
| +12% | +$421K |
|
421
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $3.53M | ﹤0.01% |
96,775
+3,569
| +4% | +$131K |
|
422
Aptiv
APTV
$9.61B
| $3.52M | ﹤0.01% |
23,624
+3,498
| +17% | +$545K |
|
423
Micron Technology
MU
$996B
| $3.46M | ﹤0.01% |
+48,792
| New | +$3.66M |
|
424
iShares Russell 1000 Growth ETF
IWF
$127B
| $3.44M | ﹤0.01% |
50,252
+7,972
| +19% | +$564K |
|
425
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $3.44M | ﹤0.01% |
68,709
-19,837
| -22% | -$1.03M |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.